Faculty of Biotechnology
The Faculty of Biotechnology employs approximately 80 academic staff members engaged in research, who are currently carrying out over 55 research projects funded by various sources (NCN, FNP, ABM). The Faculty has a Scientific Council authorized to award doctoral and postdoctoral degrees in the following disciplines: biotechnology, medical sciences, and biomedical engineering. Since 2013, the faculty has held an A+ scientific category, and in the 2021 evaluation of scientific activity under the new rules, it received an A category in two disciplines: medical sciences and biomedical engineering.
The Faculty of Biotechnology houses two specialized laboratories: the Advanced Imaging and Cytometry Laboratory and the Mass Spectrometry Laboratory. It is also home to the editorial office of the journal Cellular and Molecular Biology Letters (CMBL). CMBL is currently one of the highest-impact journals published in Poland, with an Impact Factor of 9.2.
The Faculty of Biotechnology offers first- and second-cycle degree programs in Polish and English (Biotechnology, Medical Biotechnology), as well as a 5-year integrated master’s program Molecular Medical Biotechnology which is unique in Poland. The Faculty of Biotechnology offers modern laboratories, practical classes starting from the first semesters, and opportunities for students to engage in scientific research. The Faculty also provides doctoral education at the College of Biomedical Sciences of the Doctoral School of the University of Wrocław.
The Faculty comprises 13 departments and 2 laboratories. The following are the research areas pursued at the Faculty of Biotechnology:
CELL BIOLOGY – biosynthesis of glycoconjugates, glycosyltransferases, glycosylation, membrane transporters, programmed cell death, mitochondrial ultrastructure, the role of vitamin D, endocytosis, signal transduction, lipid rafts, membrane proteins, cell membranes.
- Department of Biochemistry
- Department of Biophysics
- Department of Cytobiochemistry
- Department of Cellular Molecular Biology
CANCER CELLS AND ANTICANCER THERAPIES – targeted therapies, protein-drug conjugates, therapeutic antibodies, targeted protein degradation, liposomes, drug delivery systems, guiding molecules, signal transduction, FGF proteins, FGF receptors, immunotherapy, nanoparticles, cytoskeleton, migration, adhesion, extracellular matrix, tumor microenvironment, resistance to anticancer drugs.
- Department of Cell Pathology
- Department of Medical Biotechnology
- Department of Lipids and Liposomes
- Department of Protein Engineering
PROTEIN ENGINEERING AND THERAPEUTIC PROTEINS – nanodevices, nanomaterials, redox proteins, metalloproteins, zinc-binding proteins, protein modifications, protein stability, therapeutic proteins, targeted therapies, FGF proteins, FGF receptors, antibody-drug conjugates.
MOLECULAR MICROBIOLOGY AND ANTIMICROBIAL THERAPIES – immune response, antifungal drugs, bacterial cell cycle, targets for antibiotics, antibiotic, Streptomyces, Candida albicans, Mycobacteria, secondary metabolites, heme-binding protein, Porphyromonas gingivalis, Bacteroidota, microbiome, nanoencapsulation, antimalarial drugs, antibacterial peptides, fungal diseases.
- Department of Cellular Molecular Biology
- Department of Biotransformation
- Laboratory of Medical Biology
- Department of Genetic Biochemistry
- Department of Lipids and Liposomes
GENOME ORGANIZATION AND GENE EXPRESSION REGULATION – non-coding RNA, microRNA, RNA degradation, transcription, translation, Arabidopsis thaliana, photomorphogenesis, SUMOylation, ubiquitination, replicative stress, bacterial chromosome, secondary metabolite topology, mutations, selection, genome evolution, mitochondrial genome, cell nucleus, chromatin structure, lamin, DNA editing, epigenetics.
